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SPF ANIMALS
In 1957 Russell and Burch introduced the concept of 
the 3R’s: Replacement, Reduction and Refinement [1]. 
A few years later Henry Foster, the founder of the US 
breeding company Charles River, initiated the produc-
tion of rodents free of well-defined specific pathogens 
(SPF) by the use of caesarian section and barrier pro-
tection [2]. Since then long lists of pathogenic and op-
portunistic microorganisms have been eliminated from 
rodent breeding colonies, and laboratory rodents pur-
chased from commercial breeders today are extremely 
clean compared to fifty years ago [3]. 
Maybe these rodents are too clean. There is no doubt 
that this elimination of pathogens has improved labo-
ratory animal welfare substantially, because before that 
studies were commonly terminated due to fatal diseas-
es among the animals, such as Tyzzer’s disease, ectro-
melia and murine colonic hyperplasia, and it has had 
importance for reduction in the individual studies due 
to reduced inter-individual variation and model inter-
ference. However, pathogens are also important for the 
basic activation and the function of the immune sys-
tem [4]. Thus, it is argued that one of the reasons for 
failures of translating results from preclinical research 
to the clinical phase in some studies is due to lacking 
pathogen stimulation [4]. True is it that the immune 
system of adult laboratory mice often looks more like 
the immune system of a newborn than that of an adult 
human being [4], which may also be due to the lack of 
the symbiotic bacteria found in the microbiota of wild 
mice. 
THE IMPACT OF THE MICROBIOTA
When a scientist buys a mouse from a commercial 
vendor, he or she will get one genome with a little 
more than 20 000 functional genes. However, with the 
mouse the scientist will also get 1014 microbes, i.e. bac-
teria, archea, protozoans and phages with more than 1 
million functional genes. Dependent on which vendor 
and which room at this vendor the mouse comes from, 
these microbiotas will differ, and often this difference 
will be larger than e.g. what a change in diet can in-
duce [5]. It is clearly documented that the microbiota 
composition is of importance for the development of 
human diseases, and so, it is also important for the 
modelling of diseases in animals. For example, in hu-
mans there is a strong correlation between microbiota 
composition and clinical parameters of type 2 diabetes 
and obesity [6], and this is fully comparable to mouse 
models, in which 30-40 % of the inter-individual varia-
tion in key clinical parameters of type 2 diabetes can 
be ascribed to gut microbiota variation [7]. This is 
even higher in models of atopic dermatitis [8], while 
it is somewhat lower in models of neuro-psychiatric 
diseases [9]. As inter-individual variation is one of 
the factors determining group sizes in animal stud-
ies, there is no doubt that inter-individual microbiota 
variation therefore leads to higher group sizes or lack 
of power in studies.
ANIMALS WITH A UNIFORM MICROBIOTA
One way to solve the problem could therefore be to 
produce animals inoculated with a uniform microbiota 
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Abstract
Elimination of pathogens by laboratory rodent commercial vendors has substantially im-
proved standardized conditions as well as laboratory animal welfare. However, patho-
gens are also important for basic activation and functioning of the immune system with 
consequential influences on the symbiotic bacteria composition in the individual mi-
crobiota. One of the reasons for failures of translating results from preclinical research 
to the clinical phase in some studies could be due to unintentional selection processes. 
Some recommendations are provided to increase researchers’ awareness on this point, 
together with a practical checklist to optimize information from microbiota knowledge. 
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to achieve animals with little inter-individual variation 
or to do selective breeding to produce animals with a 
uniform microbiota. However, this is not a simple task. 
Selective breeding selecting the most similar animals 
for further mating does not seem to reduce the inter-
individual microbiota variation [10], and inoculation 
with selected microbiotas does not lead to a clustering 
of 100% between donor and recipient, and therefore 
inoculated animals still exhibit inter-individual micro-
biota variation. In principle, animals with a standard-
ized and uniform microbiota already do exist in the 
form of gnotobiotic animals. However, these animals if 
not being fully germ-free have a very little diversity in 
their microbiota, and this will probably also be the case 
for those animals produced on the basis of tailor-made 
microbiotas. 
SPECIFIC KEY BACTERIA
There are key bacteria, which are essential for the ex-
pression of a specific phenotype in the animals, e.g. a 
human disease, or which are crucial for the response 
to certain interventions tested on the animals [3]. Lit-
tman’s group experienced that they were unable to 
induce the adoptive transfer model of inflammatory 
bowel disease in mice from one vendor compared to 
their normally used vendor due to the absence of Seg-
mented filamentous bacteria (SFB’s) in the new mice [11]. 
A popular issue in the food industry is to develop oligo-
saccharides to increase the abundance of the anti-in-
flammatory bacterium Bifidobacterium. However, often 
mice from commercial breeders have no Bifidobacterium 
spp. at all, and therefore testing oligo-saccharides on 
such animals may give false negative results [3]. The 
incidence of type 1 diabetes in non-obese diabetic mice 
is to a high degree determined by the presence of Ak-
kermansia muciniphila [3]. Therefore, to avoid wasting 
animals and to increase the chance of producing trans-
lational and reproducible results rats and mice used for 
microbiota sensitive studies should be checked for the 
presence or absence of key species [3].
HUMANIZED MICROBIOTA MICE
Mice and humans on a phylum level may appear to 
have a very similar microbiota, but on genus and spe-
cies level they are quite different [12]. Inoculation with 
a human microbiota may obviously be seen as a way 
to make the mouse a more translational model for hu-
mans. However, inoculation with human microbiotas in 
mice fail to stimulate the immune system, so a microbi-
ota humanized mouse may look as naïve in its immune 
system as a germ-free mouse [13].
INCORPORATING MICROBIOTA DIVERSITY 
IN DATA EVALUATION
It is, therefore, not just around the corner to answer 
to the microbiota challenge in animal research by the 
production of animals with a fixed microbiota. The op-
posite approach may seem much more attractive, i.e. to 
strive for animals with a high diversity in microbiota and 
to monitor and describe it. Costs for microbiota charac-
terizations have decreased rapidly over the last decade. 
Much of the routine health monitoring of today can be 
done by more cost-efficient PCR methods compared to 
the so far applied bacterial cultivation, and the agent 
screening list can be reconsidered because many of the 
pathogens are seldom found in laboratory animals now-
adays [3]. Therefore, if routine health monitoring is re-
organized, it should not be difficult to find resources for 
current screening of the microbiota of animals, both on 
a colony level and down to the individuals of each study. 
It should be possible in some studies to convert maybe 
40 % of the uncontrolled variation into controlled varia-
tion. In addition, it will also reveal important informa-
tion on the impact of various microorganisms on the 
development of diseases. So, it will add to reduction 
both by allowing a smaller group size, because inter-
individual variation is controlled, and because more in-
formation per animal is created.
ENVIRONMENTAL IMPACT  
ON THE MICROBIOTA
However, controlling the microbiota of the animals 
is not enough if one wants to use microbiota consid-
erations to strive for reduction. A range of environ-
mental factors can currently change the microbiota, 
and although likely to create a lot of information, daily 
microbiota screens are not realistic. In addition, even 
though this could be done by a daily sampling of feces, 
key differences between the animals are often better 
revealed by a characterization of the cecal microbiota, 
i.e. it can only be done at termination [14]. Therefore, 
attempts should be done to keep the microbiota stable 
during the experiment. Stress is known to change the 
microbiota [15], and both during breeding and during 
Table 1
Microbiota considerations to be made prior to an animal study
Consider if there are any essential microbes, which need to be present or absent in the animal model, and if so obtain information from the 
breeding colony on the status of these microbes.
Consider if a specific diet composition is essential for the animal model.
Freeze a batch of the selected diet for the interior study and rethaw it weekly during the study.
Check that experimental design allows testing for the cage factors impact on the primary read-out.
Check that there are no known stressors in the animal room for the entire study period.
Check if staff has been appropriately trained for the procedures
Check if the animals need to be trained for the procedures
Consider if a microbiota characterization before, during and after the study will be beneficial for the data evaluation and if so plan sampling, 
and how to incorporate the characterization in the data evaluation.
Reduction and micRobiota studies
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the experiment environmental stressors such as poor 
housing, noise and untrained staff should be avoided, 
which is also relevant from a refinement point of view. 
Even commercial laboratory animal diets contains a 
range of micronutrients with impact on the microbiota, 
which vary substantially between batches, and therefore 
it should be ensured that the same batch is fed through-
out the study. This may be achieved by freezing the en-
tire amount of diet for the entire study, and at every 
feeding, thaw the amount of diet needed.
CONCLUDING REMARKS
Increased awareness of the impact of the microbiota 
is likely to result in reduction in the spirits of Russell and 
Burch, i.e. we can use fewer animals and/or obtain more 
information in each individual study. However, from an 
overall point of view it may not reduce the total num-
ber of animals used. Increased knowledge on the micro-
biota has also revealed new potentials in research, and 
the use of animal studies within the food industry, which 
has not used that many animals before, has increased in 
the search for functional foods, which can increase the 
abundances of microbes beneficial for humans. 
To obtain the full potential of microbiota knowledge 
in animal studies the simple checklist in Table 1 may be 
applied.
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